chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.33
Sex: M
Vaccine: UNK
Symptoms: Medication error, No adverse event, Product preparation error
Clinical narrative: gave the liquid DTAP IPV component of PENTACEL without reconstituting it without the ACTHIB component. with no reported adverse event; Initial information received on 28-Nov-2022 regarding an unsolicited valid non-serious case received from other health professional.  This case involves 4 months old male patient and reporter stated gave the liquid dtap ipv component of diphtheria/tetanus/5 hybrid AC Pertussis/ipv(VERO)/HIB(PRP/T) vaccine [Pentacel (Vero)] without reconstituting it without the acthib component with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine CONJ 7V (CRM197) (Prevnar); and rotavirus vaccine.  On 17-Nov-2022, the patient received first dose of 0.5 ml total of suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(VERO)/HIB(PRP/T) vaccine with standard strength (lot UJ664AAA and expiry date: 04-May-2023) via intramuscular route in the left vastus lateralis for Immunization.  On 17-Nov-2022 the patient was given the liquid dtap ipv component of pentacel without reconstituting it without the acthib component. with no reported adverse event (product preparation error) (latency: same day) .  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 79.0
Sex: F
Vaccine: FLU4
Symptoms: Skin discolouration
Clinical narrative: two to three days after vaccine, started to have discoloration of skin; there is yellow discoloration around the area of injection and it extends down arm as well; Initial information received on 28-Nov-2022 regarding an unsolicited valid non-serious case via pharmacist.  This case involves a 79-year-old female patient and the reporter stated two to three days after vaccine, started to have discoloration of skin and  there is yellow discoloration around the area of injection and it extends down arm as well after receiving influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On 23-Nov-2022, the patient received 0.7 ml total dose of suspect influenza quadrival A-B high dose HV vaccine injection (batch lot: UJ937AC) (expiry date: 30-Jun-2023) via unknown route in unknown administration site for Influenza immunization.  On an unknown date the patient had a non-serious events of two to three days after vaccine, started to have discoloration of skin ((skin discolouration) and there is yellow discoloration around the area of injection and it extends down arm as well (vaccination site discolouration) (unknown latency) following the administration of influenza quadrival A-B high dose HV vaccine.  Action taken with quadrivalent influenza vaccine (Fluzone High-Dose Quadrivalent) was not applicable.  It was not reported if the patient received a corrective treatment for the events.  Outcome: unknown for both the events.
Sex: U
Vaccine: YF
Symptoms: Medication error, No adverse event, Product preparation error
Clinical narrative: administered YF-VAX to a patient but a different diluent was used instead of the diluent supplied with the vaccine with no reported adverse event; Initial information received on 28-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient who was administered yellow fever vaccine [YF-VAX] but a different diluent was used instead of the diluent supplied with the vaccine with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a total dose of suspect yellow fever vaccine once (formulation, strength and lot number not reported) via unknown route in unknown administration site for prophylactic immunization.  On an unknown date, the YF-VAX was administered to a patient but a different diluent was used instead of the diluent supplied with the vaccine with no reported adverse event (product preparation error) (latency: same day).  It was reported, they have administered YF-VAX to a patient but a different diluent was used instead of the diluent supplied with the vaccine.   Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: RAB
Symptoms: No adverse event, Product availability issue, Product dose omission issue, Routine immunisation schedule not administered
Clinical narrative: administered 1st dose on day 0 which is on 20Nov2022 but was not able to administer 2nd dose on day 7 as there is no vaccine available, with no reported adverse event; Initial information received on 28-Nov-2022 regarding an unsolicited valid non-serious case from other health professional.  This case involves an unknown age and unknown gender patient who was administered 1st dose on day 0 which is on 20nov2022 but was not able to administer 2nd dose on day 7 as there is no vaccine available, with no reported adverse event while receiving vaccine rabies (HDC) vaccine [Imovax Rabies].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.   On 20-Nov-2022, the patient received a dose 1 of suspect RABIES (HDC) VACCINE at an unknown dose (lot number, expiry date: not reported) via unknown route in unknown administration site for immunisation.  On an unknown date, was administered 1st dose on day 0 which is on 20nov2022 but was not able to administer 2nd dose on day 7 as there is no vaccine available, with no reported adverse event (routine immunisation schedule not administered) (unknown latency) for RABIES (HDC) VACCINE.  Action taken: Not applicable.  Outcome: Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 46.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Hidradenitis, Stress, Vaccination site swelling
Clinical narrative: Hidradenitis suppurativa flare ups due to excessive stress; Excessive stress; COVID injection swole whole arm like reaction to bee sting; This spontaneous case was reported by a consumer and describes the occurrence of HIDRADENITIS (Hidradenitis suppurativa flare ups due to excessive stress), STRESS (Excessive stress) and VACCINATION SITE SWELLING (COVID injection swole whole arm like reaction to bee sting) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Hidradenitis suppurativa.    Concurrent medical conditions included Hidradenitis suppurativa (Moderate to Severe Hidradenitis Suppurativa).   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-May-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram once a day. On an unknown date, the patient experienced HIDRADENITIS (Hidradenitis suppurativa flare ups due to excessive stress), STRESS (Excessive stress) and VACCINATION SITE SWELLING (COVID injection swole whole arm like reaction to bee sting). At the time of the report, HIDRADENITIS (Hidradenitis suppurativa flare ups due to excessive stress), STRESS (Excessive stress) and VACCINATION SITE SWELLING (COVID injection swole whole arm like reaction to bee sting) outcome was unknown.            No concomitant medications were reported.   On an unknown date, the patient experienced hidradenitis suppurativa flare ups due to excessive stress, and COVID injection swole whole arm like reaction to bee sting with Adalimumab Solution for Injection, Single Dose Pen.   The reporter's causality for the event of hidradenitis suppurativa flare ups due to excessive stress unknown onset with Adalimumab Solution for Injection was no reasonable possibility. The reporter's causality for the event of COVID injection swole whole arm like reaction to bee sting with Adalimumab solution for injection was not provided. The reporter's causality for the event of COVID injection swole whole arm like reaction to bee sting with Moderna COVID-19 vaccine (Elasomeran) was reasonable possibility.  No treatment details were reported.   Reporter did not allow further contact
Age: 37.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Alopecia areata, Alopecia totalis, Biopsy skin abnormal, Laboratory test normal, Madarosis
Clinical narrative: 19 days following the vaccine, patient started losing hair from the head at an alarming rate. Continues to lose hair daily with 90% or more missing from both scalp and eyebrows.
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain, Pyrexia, Vomiting
Clinical narrative: Systemic: Body Aches Generalized-Medium, Systemic: Fever-Medium, Systemic: Vomiting-Medium
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Seizure
Clinical narrative: Systemic: seizure 12 hours after administration-Severe
Age: 22.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild
Age: 62.0
Sex: F
Vaccine: FLU4
Symptoms: Eye swelling, Mouth swelling, Swelling face, Swollen tongue
Clinical narrative: Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: Face injury, Fall, Loss of consciousness
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient was given his Covid booster and flu shot at the same time. Patient was fine after he got his Covid vaccine. Right after he got his flu shot he passed out. He was sitting in his father's lap, once he fainted he fell out of his father's lap onto the ground hitting his chin. Blood pressure and pulse were normal. EMS was called to check him out just to make sure every thing was okay since he hit his chin. EMS gave the all clear and after he sat for a few minutes he was feeling better.
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Error: Wrong Vaccine/Product Administered-
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site mass, Injection site swelling, Loss of personal independence in daily activities, Lymph node pain
Clinical narrative: I?ve had 2 Moderna initial vaccines and the first booster in 2021. This was my second booster shot, but first time with the new bivalent shot. All my shots have been Moderna. And both booster shots I?ve had this same reaction, but previously did not know how to report it. I feel a large red lump and swelling at Site of injection on arm (size of silver dollar coin witching 2-3 hours after the shot. It gets itchy within 12 hours. I take an over the counter allergy pill or Advil and helps, but then I develop swollen admit lymph nodes and groin lymph nodes on the arm/side that I received the injection within 48 hours after. Then it goes away within a week but is quite painful and makes it hard to wear certain tops/jackets and painful to use arm. Continue to take Advil or Tylenol and hot compress as needed.
Age: 41.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lymphadenopathy, Pain, Pruritus
Clinical narrative: I?ve had 2 Moderna initial vaccines and the first booster in 2021. This was my second booster shot, but first time with the new bivalent shot. All my shots have been Moderna. And both booster shots I?ve had this same reaction, but previously did not know how to report it. I feel a large red lump and swelling at Site of injection on arm (size of silver dollar coin witching 2-3 hours after the shot. It gets itchy within 12 hours. I take an over the counter allergy pill or Advil and helps, but then I develop swollen admit lymph nodes and groin lymph nodes on the arm/side that I received the injection within 48 hours after. Then it goes away within a week but is quite painful and makes it hard to wear certain tops/jackets and painful to use arm. Continue to take Advil or Tylenol and hot compress as needed.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope
Clinical narrative: Syncope Narrative:
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Hospitalization
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer 2/27/21, 3/27/21, 9/27/21, 3/31/22. Positive on 11/28/22
Age: 65.0
Sex: F
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Individual received Fluarix Quad Influenza vaccine that is eligible for those between 6 months to 64 years old. Individual was observed for 15 minutes and did not exhibit any signs/symptoms of acute anaphylaxis.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pfizer 7/16/21, 8/6/21. Positive on 11/30/22
Age: 46.0
Sex: F
Vaccine: COVID19-2
Symptoms: Body temperature increased, Chills, Fatigue, Injection site pain, Pain
Clinical narrative: Soreness at injection site within 30 minutes. Achy, fatigue, chills at 2 hrs. Elevated temp at 4 hrs. Night chills fever at 100.8 at 12 hrs.
Age: 32.0
Sex: F
Vaccine: UNK
Symptoms: Throat irritation
Clinical narrative: SCRATCHY THROAT
Age: 8.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was scheduled to receive his second monovalent dose of the series.  He was given the bivalent instead.  Pt had no adverse effects.  Contact Pfizer and our medication safety officer.  Pfizer had no instructions except that the patient should not receive an additional bivalent booster.  Medication safety officer suggested that the patient be scheduled to obtain a second monovalent in 2-3 months.  Patient is scheduled to receive in Jan of 2023.
Age: 22.0
Sex: F
Vaccine: FLU4
Symptoms: Unevaluable event
Clinical narrative: Pt received a flu dose on 9/24/22
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received Monovalent vaccine as a booster shot when Bivalent vaccine was on the market. Clinic was not up to date on most recent Bivalent vaccine recommendations, so Monovalent was being given as booster.
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: Back pain, Heart rate increased
Clinical narrative: 11/19/2022 I had the vaccine around 10:30 AM, came home and within two hours I noted my resting heart rate had gone up. My normal rate is around 60-70, kept that way by my pacemaker. My heart rate went up to 100 and stayed that way for about 36 hours, even when I went to bed. Also, I was having back pain and used a massage chair that appeared to shut down my pacemaker. My resting heart rate went down into the 50's for about 30 min. 11/20/22 I noticed during the night my heart rate went down to 75 which lasted for about 24 hours. On 11/21/22 I went to the doctor and saw the pacemaker tech and they checked out my pacemaker. The doctor reported that everything was good. On 11/21/22 in the evening, my heart rate returned to normal. I have recovered from the accelerated heart rate. I am having some other accelerated heart rates which may be related to the resetting of the pacemaker, but I have to check with the doctor regarding the settings of the pacemaker.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: SORE THROAT
Age: 17.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: second flu dose administered 1.5month  after  first flu vaccine was given to her
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient had received 1st dose of monovalent Pfizer COVID vaccine and 2nd dose of monovalent Moderna COVID vaccine, which was documented. Moderna dose was not documented in internal medical record, so clinic personnel thought patient had not completed primary series. Administered monovalent Pfizer COVID vaccine when bivalent Pfizer COVID booster was available and should have been given per recommendations.
Age: 5.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was scheduled to receive his second monovalent vaccine.  The patient was given a Bivalent vaccine instead.  No adverse reactions noted by the parents.  Pfizer was notified and provided the information that no further Bivalent vaccine should be given at this time.  Reached out to our medication safety officer who suggested that the patient come in for his second monovalent 2-3 months.  Parents were notified and the patient is scheduled to receive his second monovalent in Jan 2023.
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was scheduled to receive his second monovalent vaccine.  The patient was given a Bivalent vaccine instead.  No adverse reactions noted by the parents.  Pfizer was notified and provided the information that no further Bivalent vaccine should be given at this time.  Reached out to our medication safety officer who suggested that the patient come in for his second monovalent 2-3 months.  Parents were contacted and left a message to call back the office.  No return call has been made.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased
Clinical narrative: DECREASE O2
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea
Clinical narrative: NAUSEA, DIARRHEA
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient had completed primary series and received monovalent vaccine as a booster shot when bivalent vaccine was on the market. Clinic was not up to date on most recent bivalent vaccine recommendations, so monovalent was being given as booster.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: I did not have a reaction to the vaccine. I did not have symptoms prior to testing positive. I had been exposed to COVID-19 at my job and with patients. I woke up on 11/30/2022 with a scratchy throat and so nose like I was getting sick with a sinus infection. I tested two times with a home test on 11/30/2022 and both were positive for COVID-19.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient had completed primary series and received monovalent vaccine as a booster shot when bivalent vaccine was on the market. Clinic was not up to date on most recent bivalent vaccine recommendations, so monovalent was being given as booster.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient had completed primary series and received monovalent vaccine as a booster shot when bivalent vaccine was on the market. Clinic was not up to date on most recent bivalent vaccine recommendations, so monovalent was being given as booster.
Age: 91.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Vaccinated and boosted.  COVID breakthrough infection
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated and boosted.   COVID breakthrough infection
Age: 39.0
Sex: M
Vaccine: FLU4
Symptoms: Hypersensitivity, Immunisation reaction, Urticaria
Clinical narrative: MEMBER WAS GIVEN INFLUENZA VACCINE AT 3:00PM, ON 30NOV22, AND STARTED HAVING HIVES AT ABOUT 3:45, MEMBER WAS SEEN AT THE LOCAL EMERGENCY ROOM FOR AN ADVERSE REACTION TO VACCINE, MEMBER WAS TREATED FOR AN ALLERGIC REACTION AND WAS RELEASED THE SAME DAY WITH OVERALL IMPROVED SYMPTOMS. PATIENT TREATED WITH ANTIHYSTAMINES AND STERIODS.
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED BEYOND EXPIRATION DATE OF 11/21/2022.
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Administration site pain, Arthralgia, Chest discomfort, Chest pain, Condition aggravated
Clinical narrative: This is what the patient reported in our hospital reporting record.  I received the flu shot on Monday, 11-21-22, at clinic. I had waited until late November because I had been diagnosed with myopericarditis in August and I was waiting (on the advice of my cardiologist) until I had a decrease in frequency in my chest discomfort (and therefore hopefully an increase in healing) before taking a vaccine which could potentially aggravate the condition. After the vaccine, I had some soreness in my upper arm at the administration site within 24 hours, which was expected. However, 24 hours after the vaccine, I began to experience severe ankle pain in both ankles unrelated to any other activity, which lasted through Sunday (11-27-22) and finally began to improve Monday (11-28-22). I experienced an increase in chest discomfort (squeezing, pain) frequency compared to before the vaccine, and it is ongoing (and more frequent than before). I informed my cardiologist, clinic, and one of my supervisors.
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED BEYOND USE DATE OF 11/21/2022
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Memory impairment, Renal pain
Clinical narrative: I am experiencing kidney pain post vaccination.  It is bilateral and rates a 2-3/10.  I am remembering now that I had this after other COVID vaccinations, but memory fails on the details.  I had written it off to other causes but felt today when I made the connection, that I should report it.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case
Age: 89.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED BEYOND EXPIRATION DATE OF 11/21/2022
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough case  dose 1 Moderna 3/4/21 030A21A
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE ADMINISTERED BEYOND DATE OF 11/21/2022
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood test, Computerised tomogram abnormal, Lymphadenopathy
Clinical narrative: I had my annual physical on Nov 3 with my Dr..  As part of physical had blood test and cat scan scheduled.  Blood test done on Nov. 8 and cat scan done on Nov 10.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest X-ray, Chest pain, Myalgia
Clinical narrative: Chest pain beginning about a week after injection, sharp stabbing pain and times and aches in the chest and back muscles at other times
Age: 19.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Received bivalent booster instead of primary series for 2nd dose
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chills, Muscle spasms, Nausea, Pyrexia
Clinical narrative: Call from client today.  States within 6-12 hours of getting his Moderna Booster at 1:30 on 11/28/22 he developed high fever (he never measured his fever), severe chills to the point of spasms and nausea for 3 days.   Symptoms were controlled with Ibuprofen, he called his doctor but was not seen, no hospitalization.  He was insistant that a report be filed.  I recommended he get tested for flu or covid but he declined.  Stated he knew his body and it was a reaction to the vaccine.  It was his 5th covid vaccine, only moderate side effects with first dose.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient admitted with COVID-19.  He has had a total of 5 vaccines and boosters.
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Paraesthesia, Sciatica, Skin disorder
Clinical narrative: I had a mark on my face under my chin and on my face, my face was tingling as well. I was given an antiviral and an ointment which healed the area in one week to one and a half weeks. Two weeks later I went back to urgent care and was diagnosed with a sciatica problem.
Age: 17.0
Sex: F
Vaccine: FLU4
Symptoms: Cardiac telemetry, Chest pain, Dyspnoea, Echocardiogram normal, Electrocardiogram low voltage
Clinical narrative: Acute onset of chest pain about 4 days post flu shot (and 3-4 weeks post viral URI-COVID neg on home test X2) that was retrosternal and compressive. Associated symptom: shortness of breath. No fever, no URI or GI symptoms, no rash. Hemodynamically stable. Labs showed troponin of 8,980 at maximum. EKG with low voltage precordial leads. Echo normal. Respiratory panel negative. COVID and enterovirus negative.  Received supportive care and on telemetry for about 36 hrs. Troponin trended down. Following with cardiology.
Age: 17.0
Sex: F
Vaccine: FLU4
Symptoms: Enterovirus test negative, Respiratory viral panel, SARS-CoV-2 test negative, Troponin increased
Clinical narrative: Acute onset of chest pain about 4 days post flu shot (and 3-4 weeks post viral URI-COVID neg on home test X2) that was retrosternal and compressive. Associated symptom: shortness of breath. No fever, no URI or GI symptoms, no rash. Hemodynamically stable. Labs showed troponin of 8,980 at maximum. EKG with low voltage precordial leads. Echo normal. Respiratory panel negative. COVID and enterovirus negative.  Received supportive care and on telemetry for about 36 hrs. Troponin trended down. Following with cardiology.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: none
Age: 78.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Oedema, Skin warm
Clinical narrative: Redness in the arm, spreading down towards elbow, warm to touch, slight edema
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Endotracheal intubation, Intensive care
Clinical narrative: pt hospitalized 5/2/22 for aspiration PNA; required intubation; ICU; complicated hospitalization by testing positive for COVID, COVID PNA , on 5/31/22; condition did not improve; palliatively extubated on 6/22/22 and pt passed away in the hospital
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia aspiration, SARS-CoV-2 test positive
Clinical narrative: pt hospitalized 5/2/22 for aspiration PNA; required intubation; ICU; complicated hospitalization by testing positive for COVID, COVID PNA , on 5/31/22; condition did not improve; palliatively extubated on 6/22/22 and pt passed away in the hospital
Age: 30.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Biopsy skin abnormal, Guttate psoriasis, Injection site swelling, Pruritus
Clinical narrative: Severe swelling of both injection sights within 24-48 hours of administered dose. Developed Guttate Psoriasis within 2 weeks of first dose, limited to the arm of where the vaccines were administered. Full body Guttate psoriasis developed within 1 week of second dose to include scalp, nose, shoulders, arms, chest, back, groin, legs and feet. Severe itching all over body.
Age: 34.0
Sex: M
Vaccine: FLUC4
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Patient received a flu shot instead of the Moderna booster that he had made an appointment for. He had already received a flu shot two months before that.
Age: 78.0
Sex: M
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Patient received a high dose flu vaccine in error as he had already received a flu vaccine on 10/13/2022.
Age: 50.0
Sex: F
Vaccine: UNK
Symptoms: Abdominal pain upper, Dizziness, Feeling of body temperature change, Hot flush, Nausea
Clinical narrative: Woke up in the middle of the night with severe nausea, dizziness, stomach pain, ringing in the ears, hot and cold flashes, almost fainted.
Age: 50.0
Sex: F
Vaccine: UNK
Symptoms: Tinnitus
Clinical narrative: Woke up in the middle of the night with severe nausea, dizziness, stomach pain, ringing in the ears, hot and cold flashes, almost fainted.
Age: 61.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, Arthritis, Decreased activity, Gait disturbance, X-ray normal
Clinical narrative: This was my first ever Flu vaccine.  Developed severe knee/joint pain (right more than left, mostly while standing/walking) over a few months.  Serious pain lasted approximately 4 months with painful limping and reduced activity.  Pain gradually subsided over a few months.  X-rays did not show anything unusual.  Specialist thought inflamation was a problem in the right knee. No trauma was suspected. Treatment consisted of exercise (as able), high doses of Curcumin, and Tylenol.  It is worth noting that I received my initial COVID vaccinations at the beginning of the year (about 7 months prior to the Flu Vaccination) and a booster dose in January after the Flu Vaccine, that may have aggravated these symptoms.
Age: 9.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: The moderna dose that was administered on 11/21 was from a lot that had expired on 11/17. There have been no known adverse reactions. The manufacturer has been contacted for viability. The patient will continue the primary series as recommended, so he will receive his second dose in at least one month from 11/21.
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: Aphthous ulcer, Blister, Crying, Lip erythema, Lip injury
Clinical narrative: Cold sores developed overnight below the right half of my lower lip (itching, burning blisters, weeping). Right side of lower lip has swollen to maximum size (throbbing, red, stretched skin to the size of a grape tomato.) Canker sore developed on the inside of that area, but that may be due to accidentally biting the swollen lip while eating. Ongoing. It may be worth noting that I've only had one cold sore before and it was earlier this year (Feb 2022). So they are not something I experience frequently.
Age: 40.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lip swelling, Oral herpes, Pain, Pruritus, Skin burning sensation
Clinical narrative: Cold sores developed overnight below the right half of my lower lip (itching, burning blisters, weeping). Right side of lower lip has swollen to maximum size (throbbing, red, stretched skin to the size of a grape tomato.) Canker sore developed on the inside of that area, but that may be due to accidentally biting the swollen lip while eating. Ongoing. It may be worth noting that I've only had one cold sore before and it was earlier this year (Feb 2022). So they are not something I experience frequently.
Age: 25.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Immediate post-injection reaction, Injection site pain, Lymphadenopathy, Musculoskeletal stiffness
Clinical narrative: Injection site pain for both arms (started almost immediately)  Swollen and painful lymph nodes under arm that had the COVID booster administered (started within 24 hours)  Muscle pain and stiffness around shoulder of arm given the Flu vaccine (started right around 24 hours)
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Discomfort, Dysstasia, Emotional distress, Feeling of body temperature change
Clinical narrative: I had a fever, felt nausea, hot and cold body chills, shakes, ache pain in body and a shooting pain in my legs. I could not stand for long period of time. I had to immediately lie down and struggle to drink water to help alleviate my pain and discomfort.  As a result of this I called out of work as a worker working from home.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Nausea, Pain, Pain in extremity, Pyrexia
Clinical narrative: I had a fever, felt nausea, hot and cold body chills, shakes, ache pain in body and a shooting pain in my legs. I could not stand for long period of time. I had to immediately lie down and struggle to drink water to help alleviate my pain and discomfort.  As a result of this I called out of work as a worker working from home.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: I had a fever, felt nausea, hot and cold body chills, shakes, ache pain in body and a shooting pain in my legs. I could not stand for long period of time. I had to immediately lie down and struggle to drink water to help alleviate my pain and discomfort.  As a result of this I called out of work as a worker working from home.
Age: 76.0
Sex: F
Vaccine: FLUA4
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Patient states she believes her vaccine was given too low as she has chronic upper arm and shoulder pain.  She thinks a nerve was hit and now she can't raise her arm more than 90 degrees.  She said the vaccine hurt during administration and from then on.  She can't sleep on her arm as it hurts if she presses on a spot below her deltoid and if she raises her arm.  Her doctor stated it is from her flu shot most likely given too low.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Patient had a breakthrough infection. Positive COVID test on 1/28/2022. Patient passed away on 3/12/2022.
Age: 6.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: None adverse affect she was given shots when not needed.
Age: 26.0
Sex: F
Vaccine: COVID19-2
Symptoms: Exposure during pregnancy, Incorrect product formulation administered
Clinical narrative: OB patient (13 week gestation, EDC 6/3/2023) due for 2nd Covid shot.  First shot Monovalent was given  11/2/22.  Was inadvertently given Bivalent 0.5ml today.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Loss of personal independence in daily activities, Pain, X-ray normal
Clinical narrative: Developed severe knee/joint pain (right more than left, mostly while standing/walking) over a few months.  Serious pain lasted approximately 4 months with painful limping and reduced activity.  Pain gradually subsided over a few months.  X-rays did not show anything unusual.  Specialist thought inflamation was a problem in the right knee. No trauma was suspected. Treatment consisted of exercise (as able), high doses of Curcumin, and Tylenol.  It is worth noting that I also received my first ever Flu Vaccine in September of 2021 (before onset of symptoms) and a COVID Booster in January 2022 (during onset of symptoms) that may have aggravated these symptoms.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Headache, Influenza, Injection site pain, Injection site pruritus
Clinical narrative: Injection site: itching and severe pain with contact and arm use; overall: severe malaise, severe headache, minor to moderate stomach pain, nausea, overall bad flu feeling. Folks need to be warned they may need support to manage children and take a day or 2 off for these symptoms. I am a single mom, nurse, and had not expected this severe of an immune response.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Malaise, Nausea, Pain
Clinical narrative: Injection site: itching and severe pain with contact and arm use; overall: severe malaise, severe headache, minor to moderate stomach pain, nausea, overall bad flu feeling. Folks need to be warned they may need support to manage children and take a day or 2 off for these symptoms. I am a single mom, nurse, and had not expected this severe of an immune response.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Influenza like illness, Pruritus, Rash, SARS-CoV-2 test negative
Clinical narrative: Vaccinated 11/18/22;  rash started 11/24/22 and has progressively spread from back to chest, axilla and now onto legs. Face is currently spared.  Member seen by Dermatologist and given RX : TAC ointment  ).05%  applying daily. Itching is very intense: Benadryl gel seems to help. Member has Flu like symptoms , but is testing Covid negative. ( patient had a small rash mid low back, sacral area; that appeared after 4th vaccine in July 2022: was told a patch of psoriasis and given the Clobetasol Foam 0.05% to use bid).  After this last vaccine: the back patch increased in size and then started to progress farther and farther out; now entire back , torso, chest, axilla and posterior legs are involved.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Female sex hormone level, Heavy menstrual bleeding, Immediate post-injection reaction
Clinical narrative: Severe fatigue and back pain around site of previous surgery (T8-9 laminectomy w Syringo-subarachnoid shunt) for about 6-7 days immediately following 3rd dose and moderate to severe menorrhagia beginning around 7/5/22 with menstrual bleeding lasting daily or near daily until 10/25/22.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test
Clinical narrative: Severe fatigue and back pain around site of previous surgery (T8-9 laminectomy w Syringo-subarachnoid shunt) for about 6-7 days immediately following 3rd dose and moderate to severe menorrhagia beginning around 7/5/22 with menstrual bleeding lasting daily or near daily until 10/25/22.
Age: 1.0
Sex: F
Vaccine: HIBV
Symptoms: Injection site nodule
Clinical narrative: knot on right thigh at injection site, warm compresses and observation
Age: 44.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19 contracted on or about 11/21/2022.
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given .2 ml of the dose for 12-18 year olds- No adverse reaction just reporting due to being COVID vaccine related
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Patient had breakthrough infection and later passed away from complications.
Age: 9.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given COVID booster for ages 12-18, no adverse reactions just reporting due to COVID vaccine
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: FEVER 103
Age: 31.0
Sex: M
Vaccine: FLU4
Symptoms: Borrelia test, Facial paralysis, Hypoaesthesia
Clinical narrative: Employee developed numbness  lt face and lt facial droop 2 hrs after the flu injection' He was taken to the ED where he was given Deltasone 80mg po x 6 days and carboxymethylcellulose 1 drop to the left eye. He had no other symptoms.  He was stable no further progression of the paralysis.  He will be followed.  no restrictions. He reports that his mother had a similar reaction to flu vaccine years ago.
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient was given booster for ages 12-18, no adverse reactions just submitting due to COVID vaccine
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asymptomatic COVID-19
Clinical narrative: ASYMPTOMATIC
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Malaise, Pain, Respiratory tract congestion
Clinical narrative: After receiving the vaccine, I had body aches and felt tired for about 24 hours. On 11/24/2022 I started not feeling well with congestion, so I took a COVID-19 test and it was negative. On 11/25/2022, I took another COVID-19 home test and it was positive. I contacted my doctor and was given a prescription for PAXLOVID and they recommended that I take an expectorant. After three doses of PAXLOVID, I started feeling better.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: After receiving the vaccine, I had body aches and felt tired for about 24 hours. On 11/24/2022 I started not feeling well with congestion, so I took a COVID-19 test and it was negative. On 11/25/2022, I took another COVID-19 home test and it was positive. I contacted my doctor and was given a prescription for PAXLOVID and they recommended that I take an expectorant. After three doses of PAXLOVID, I started feeling better.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: 20 minutes after receiving 1st booster of Novavax patient complaint of hives and itchiness on her left arm, part of the neck area. no complains of chest pain or shortness of breath. Patient asked and was given Benadryl 25 mg/50mg po and vital signs were monitored. 5 minutes after medication was given patients rashes and itchiness subsided. Vital signs were normal. Patient was stable and was released from vaccination site.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Respiratory arrest, SARS-CoV-2 test positive
Clinical narrative: Patient had COVID 19 vaccines given on: 07/30/21, 8/21/21, 01/20/22 and 10/25/22.  Patient tested positive for COVID 19 on 11/15/22 -- patient was asymptomatic at time of test and remained asymptomatic  while isolated.   Patient was DNR and CTB on 11/28/22
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Discomfort, Face and mouth X-ray, Glossodynia, Muscle disorder, Oral pain
Clinical narrative: Oral pain.  Upper and lower right side molar area.  Tongue sensitivity. Left side jaw muscle wanted to lock.
Age: 0.33
Sex: M
Vaccine: RV1
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Given 2nd dose of Rotarix 6 days too soon.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash, Injection site warmth, Rash pruritic
Clinical narrative: Very intense localized rash developed at injection site. Lasted about 5 days and was itchy / hot too touch.
Age: 90.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was indicated for second dose in covid-19 primary series, however bivalent booster was accidently administered. Error was realized immediately after, no adverse events noted. No additional dose was administered under the guidance of CDC Covid-19 vaccine administration errors and deviations recommendations.
Age: 1.08
Sex: M
Vaccine: COVID19
Symptoms: Injection site nodule, Injection site pruritus, Injection site warmth, Skin reaction
Clinical narrative: Localized skin reaction at the injection site?itchy, hot to touch + felt like a bump under skin. Lasted about 4-5 days.
Age: 49.0
Sex: F
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site joint pain, Neck pain
Clinical narrative: Immediately upon injection I felt a pain go up my neck. The neck pain subsided but my shoulder joint was very achy for several days. Instead of improving, the pain persisted and has developed to limiting my range of motion.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine administered expired on 7/31/2022.  Pt experienced no adverse reactions.
Age: 40.0
Sex: M
Vaccine: COVID19-2, FLUC4
Symptoms: Anticoagulant therapy, Chest pain, Computerised tomogram thorax abnormal, Embolism, Gene mutation identification test
Clinical narrative: The evening of receiving the vaccine, I began having extreme chest pain on the left side of my chest, significant pain when breathing, and eventually to urgent care and ER from there. They performed a CT scan and discovered three embolisms in my chest. They put me on blood thinners. I was admitted in the hospital for 36 hours before being discharged, and they prescribed me ELIQUIS for the time being for blood thinners and prevent clotting. I have a follow-up with a cardiologist in February to perform another CT scan to ensure the clots have resolved themselves and a genetic testing to see how the clots formed.
Age: 40.0
Sex: M
Vaccine: COVID19-2, FLUC4
Symptoms: Painful respiration
Clinical narrative: The evening of receiving the vaccine, I began having extreme chest pain on the left side of my chest, significant pain when breathing, and eventually to urgent care and ER from there. They performed a CT scan and discovered three embolisms in my chest. They put me on blood thinners. I was admitted in the hospital for 36 hours before being discharged, and they prescribed me ELIQUIS for the time being for blood thinners and prevent clotting. I have a follow-up with a cardiologist in February to perform another CT scan to ensure the clots have resolved themselves and a genetic testing to see how the clots formed.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Blood glucose normal, Differential white blood cell count abnormal, Dizziness, Dyspnoea
Clinical narrative: Pt. is a 60 y.o. male who presents to the Emergency Department with complaints of fever shortness of breath and weakness.  Status post varicella-zoster vaccine yesterday.  Weakness.  States he felt like he was going to pass out.  Body aches.  No vomiting or diarrhea.  No paresthesias.  Moderate severity worsens with activity relieved with rest.  No chest pain.  Has had shortness of breath."  BP 169/82  | Pulse 86  | Temp 99.1 °F (37.3 °C) (Oral)  | Resp 16  | Wt (!) 103.4 kg (228 lb)  | SpO2 93%  | BMI 30.92 kg/m²   Pt given duoneb nebulizer solution and IV decadron, normal saline, and toradol before being discharged.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Electrocardiogram QT interval normal, Electrocardiogram normal, Eosinophil count decreased, Eosinophil percentage decreased, Full blood count abnormal
Clinical narrative: Pt. is a 60 y.o. male who presents to the Emergency Department with complaints of fever shortness of breath and weakness.  Status post varicella-zoster vaccine yesterday.  Weakness.  States he felt like he was going to pass out.  Body aches.  No vomiting or diarrhea.  No paresthesias.  Moderate severity worsens with activity relieved with rest.  No chest pain.  Has had shortness of breath."  BP 169/82  | Pulse 86  | Temp 99.1 °F (37.3 °C) (Oral)  | Resp 16  | Wt (!) 103.4 kg (228 lb)  | SpO2 93%  | BMI 30.92 kg/m²   Pt given duoneb nebulizer solution and IV decadron, normal saline, and toradol before being discharged.